Freundt E A
J Biol Stand. 1983 Jul;11(3):227-40. doi: 10.1016/s0092-1157(83)80010-9.
A total of 29 Mycoplasma and Acholeplasma antiserum reagents produced in mules and horses by the Baltimore Biological Laboratory and by Huntingdon Research Centre, under the auspices of National Institutes of Health, Bethesda, USA, were tested for potency and specificity, by a great variety of serological techniques, at the FAO/WHO Collaborating centre for Animal Mycoplasmas, University of Aarhus, Denmark. Subsequently, the antisera were subjected to a collaborative assay in which 20 workers from 15 different laboratories participated under the auspices of the International Research Programme on Comparative Mycoplasmology, International Organization for Mycoplasmology (IOM). Each antiserum was tested for homologous and heterologous reactivity by the growth inhibition (GI) and metabolism inhibition (MI) tests in at least two different laboratories. In addition, nine antiserum reagents were subjected in the lyophilized state to accelerated thermal degradation tests. The overall picture of the results obtained with the GI test was that of a remarkable degree of agreement among observations made in the different laboratories and with those originally reported by the Collaborating Centre. Results obtained with the MI test generally showed greater variation from one laboratory to another and, to some extent, on repeated testing of a serum in the same laboratory. From the combined results of the two tests the potencies of nine antisera were considered to be below acceptable levels for reference reagents. The potency of the remaining 20 antisera ranged from satisfactory to very high levels. Additionally these sera proved highly specific in both tests. The results of the thermal degradation tests carried out on about one-third of the serum reagents showed the stability of these reagents to be very satisfactory and to satisfy international requirements. It was concluded that although the antisera tested could not be established as standard reference reagents they should be regarded as working reagents. In this capacity they have already proved extremely useful in a great many mycoplasma laboratories all over the world.
在美国国立卫生研究院(位于贝塞斯达)的支持下,由巴尔的摩生物实验室和亨廷顿研究中心用骡和马制备的总共29种支原体和无胆甾原体抗血清试剂,在丹麦奥胡斯大学的粮农组织/世卫组织动物支原体合作中心,通过多种血清学技术对其效价和特异性进行了检测。随后,这些抗血清进行了一项协作检测,在国际支原体学组织(IOM)的比较支原体学国际研究计划的支持下,来自15个不同实验室的20名工作人员参与其中。每种抗血清至少在两个不同实验室通过生长抑制(GI)和代谢抑制(MI)试验检测其同源和异源反应性。此外,9种抗血清试剂以冻干状态进行加速热降解试验。GI试验获得的结果总体情况是,不同实验室的观察结果之间以及与合作中心最初报告的结果之间存在显著程度的一致性。MI试验获得的结果通常显示,不同实验室之间以及在同一实验室对血清进行重复检测时,在一定程度上存在较大差异。从两项试验的综合结果来看,9种抗血清的效价被认为低于参考试剂的可接受水平。其余20种抗血清的效价范围从令人满意到非常高。此外,这些血清在两项试验中均证明具有高度特异性。对约三分之一的血清试剂进行的热降解试验结果表明,这些试剂的稳定性非常令人满意,符合国际要求。得出的结论是,尽管所检测的抗血清不能被确立为标准参考试剂,但应将它们视为工作试剂。就这一身份而言,它们已在世界各地的许多支原体实验室中证明极其有用。